In bounameaux h ed low molecular weight heparins in prophylaxis and therapy of thromboembolic diseases vol 19 of fundamental and clinical cardiology new york marcel dekker 199475 127. Prevention and treatment of venous thromboembolism with low molecular weight heparins clinical implications of the recent european guidelines paolo prandoni 1 1 department of cardiothoracic and vascular sciences thromboembolism unit university of padua italy. Venous thromboembolism prophylaxis deep vein thrombosis pulmonary embolism lung resection low molecular weight heparin additional relevant mesh terms thromboembolism embolism venous thromboembolism pulmonary embolism lung neoplasms embolism and thrombosis vascular diseases cardiovascular diseases lung diseases respiratory tract diseases . Low molecular weight heparins in prophylaxis and therapy of thromboembolic diseases henri bounemeaux new york 1994 marcel dekker inc 323 pages 125 the advent of low molecular weight lmw heparins has generated considerable excitement in all fields of medicine. Both unfractionated heparin and low molecular weight heparin are approved for venous thromboembolism prophylaxis versus unfractionated heparin for thromboembolism prophylaxis for medical
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.